Company intelligence / Profile preview

GenoBioTX

Sugar Land, Texas, United Statesgenobiotx.com ↗

Ownership: Private
Development stage: Commercial

Overview

GenoBioTX provides advanced genetically engineered animal and cell line models to accelerate preclinical drug discovery. Their expertise includes developing humanized mouse models for immune checkpoint research and other disease-relevant targets. They support academic institutions as well as biotech/pharma companies with tailored solutions in oncology/immunology research. No direct clinical results as they do not develop drugs themselves.

Therapeutic areas: OncologyMetabolic DisordersInfectious Diseases
Modalities: Gene editingCRISPR-based therapyTransgenic animal modelsAntibody-drug conjugate (preclinical model development)
Industry: Drug Discovery Services

Partnerships

Collaborates with academic institutions and pharmaceutical/biotech companies globally; specific partners not listed publicly.

Beyond the preview

Go deeper on GenoBioTX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenoBioTX.

Explore the full profile